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Hepatitis C virus (HCV) is a unique enveloped virus that assem-
bles as a hybrid lipo-viral particle by tightly interacting with
host lipoproteins. As a result, HCV virions display a characteristic
low buoyant density and a deceiving coat, with host-derived
apolipoproteins masking viral epitopes. We previously described
methods to produce high-titers preparations of HCV particles with
tagged envelope glycoproteins that enabled ultrastructural anal-
ysis of afﬁnity-puriﬁed virions. Here, we performed proteomics
studies of HCV isolated from culture media of infected hepatoma
cells to deﬁne viral and host-encoded proteins associated with
mature virions. Using two different afﬁnity puriﬁcation protocols,
we detected 4 viral and 46 human cellular proteins speciﬁcally
co-purifying with extracellular HCV virions. We determined the C
terminus of the mature capsid protein and reproducibly detected
low levels of the viral nonstructural protein, NS3. Functional char-
acterization of virion-associated host factors by RNAi identiﬁed
cellular proteinswith either pro- or anti-viral roles. In particular, we
discovered a novel interaction betweenHCV capsid protein and the
nucleoporin Nup98 at cytosolic lipid droplets that is important for
HCV propagation. These results provide the ﬁrst comprehensive
view of the protein composition of HCV and new insights into the
complex virus-host interactions underlying HCV infection.
enveloped virus j hepacivirus j virion proteomics j virus assembly j
virus-host interactions
Introduction
Compositional studies of virions provide powerful clues for un-
derstanding the functions of viral proteins, assembly and entry
pathways and more broadly, mechanisms of virus-host interac-
tions. Increasingly sensitive mass spectrometry techniques have
enabled the detection of viral and cellular proteins that are
incorporated in virions even at very low levels (1).
Hepatitis C virus (HCV) is a positive-sense, single stranded
RNA virus of the Flaviviridae family. This bloodborne pathogen
causes chronic liver infection that develops into cirrhosis and
hepatocellular carcinoma and is the leading indication for liver
transplantation. Over 185 million people are chronically infected
with HCV (2). Despite great advances in the ability to study this
virus in vitro, significant gaps remain in our understanding of the
infectious particle and the virus-host interactions required for
HCV propagation.
The protein composition of HCV is not known. While the
capsid protein, Core, and the E1 and E2 envelope glycopro-
teins are thought to be the major constituents of the virion, it
remains to be determined if nonstructural (NS) viral proteins
are packaged as well. A growing body of literature suggests that
cellular proteins are important components of HCV. Indeed, this
virus closely associates with low- (LDL) and very-low density
lipoprotein (VLDL) components, forming a chimeric lipo-viral
particle (LVP). Biochemical and ultrastructural studies demon-
strated that infectious HCV particles are coated with endogenous
apolipoproteins that play key roles in viral attachment and entry,
explaining the higher infectivity of lipoprotein-associated HCV
(2).
The heterogeneous size and appearance of extracellular
HCV, ranging from 40 to >100 nm in diameter, suggests that the
set of associated proteins (both viral and cellular), as well as their
stoichiometry, might vary across the virion population. Addition-
ally, the specific infectivity of HCV changes according to the cell
system/host that the virus is produced in, highlighting a strong
contribution of the host to the makeup of the virus particles (2).
Therefore, a proteomic analysis of HCV represents an attractive
means of discovering novel virus-host interactions with possible
implications for understanding exploitation/subversion strategies
that this chronic virus uses to persist within the host.
We recently described twomethods for producing and affinity
purifying high titers of cell culture derived HCV (HCVcc) that
enabled ultrastructural analysis of HCV virions (3). The first was
based on the construction of an infectious clone with tags fused at
the N-terminus of E2, while the second relied on the use of potent
HCV neutralizing antibodies.
In this study, we used both affinity-purification approaches
to perform proteomic analysis of extracellular HCV virions. We
established that Core177 (aa 1-177) is the form incorporated in
matureHCVparticles and detected a number of virion-associated
virus and host-derived proteins. Functional characterization of
HCV-associated cellular proteins identified new host factors,
including a nuclear pore complex protein, that participate inHCV
infection.
Signiﬁcance
Virion proteomics represents a powerful and unbiased ap-
proach to gain insights into the process of virus assembly and
the host factors important for infection. For hepatitis C virus
(HCV), it is known that infectious virions are assembled along-
side endogenous lipoproteins to give rise to a chimeric lipo-
viral particle. Host-derived apolipoproteins coat the exterior
of circulating particles, making for a veiled pathogen. The pro-
tein composition of HCV remains, however, undeﬁned. Here,
using mass spectrometry, we identiﬁed novel viral and cellular
proteins speciﬁcally associated to HCV virions and discovered
an essential interaction between the capsid protein and the
nucleoporin Nup98 that is required for virion biogenesis.
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Fig. 1. HCV puriﬁcation ﬂowchart. Schematic description of the steps used
to purify extracellular HCV virions.
Fig. 2. Analysis of puriﬁed HCV virions. (A-B) TEM images of puriﬁed HCV
particles used for proteomics studies. Scale bars, 100nm. (C-D) Coomassie
staining of SDS-PAGE gels subjected to proteomics analysis. Stars indicate
the slices where E2, NS3 and Core (top to bottom) were detected; diamonds
show the heavy and light antibody chains. Table 1. Viral proteins in puriﬁed
HCV virions.
Results
Purification of extracellular HCV virions. Several challenges
hampered compositional studies of patient-derived virus or HCV
grown in primary hepatocyte cultures. These include the presence
of neutralizing antibodies in the plasma of infected patients that
interfere with the isolation of circulating virions, the high back-
ground from serum proteins, the limited availability, prohibitive
costs and short survival of primary human hepatocytes in cell
culture, as well as their low permissiveness to HCV infection. In
contrast, large volumes ofHCVcc-containing supernatants can be
produced in serum-free or low serum-containing media and viral
envelope proteins can be tagged to facilitate virion affinity pu-
rification. Large-scale electroporations of HCV RNA into Huh-
Table 1. Viral proteins in puriﬁed HCV virions.
Protein tag-
HCV wt-HCV ￿-HCV ￿-HIV
E2 Log (e) -23 - -18 -
Seq cov corr 34 - 35 -
Unique
peps
3 - 3 -
Spectra 6 - 6 -
CORE Log (e) -130 -9 -94 -
Seq cov corr 85 14 36 -
Unique
peps
13 1 9 -
Spectra 41 2 32 -
NS3 Log (e) -3.7 - -3.4 -
Unique
peps
1 - 1 -
Spectra 2 - 1 -
Sequences SIDFIPVETLDVVTR APITAYAQQTR
Fig. 3. Identiﬁcation of the C-terminus of mature Core in extracellular HCV
virions.(A) Amino acid sequence of Core corresponding to residues 1-191
of the J6 HCV polyprotein, genotype 2a. The underlined sequences were
identiﬁed in the database search. Trypsin cleavage sites are shown in bold,
while the most C-terminal peptide cleavage site is shown in red.(B)Schematic
representation of the junction between Core and E1.The predicted sequence
and calculated protonated masses (MH+) of clone 2 Core peptide generated
by cleavage with exogenous Trypsin protease and the host signal peptide
peptidase (SPP) are indicated in red andmatch the observed data. Full length
Core (191 aa) is generated by cleavage of the signal peptidase (SP), while
mature Core is produced by SPP-mediated cleavage at position 177. Table 2.
HCV-associated cellular proteins selected for follow-up studies.
Fig. 4. Functional classiﬁcation of host proteins in HCV virions according to
their known cellular functions.
7.5.1 hepatoma cells were carried out and cell supernatants were
harvested every 3-6 hours up to 120 hours post-electroporation
and stored at 4C to minimize temperature-dependent inactiva-
tion of HCV (Fig. 1). Between 12 and 15 liters of HCV-containing
media were produced and concentrated in a nitrogen-pressurized
ultrafiltration cell using low protein-binding membranes with
a molecular weight cut off (MWCO) of 100kDa that retained
>85%of the viral infectivity (Fig. S1C andTable S1). Two sequen-
tial affinity purification steps were used to enrich for envelope-
containing particles. The first one relied on a high-affinity in-
teraction between heparin and E2. Although the heparin-eluted
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Table 2.
# Identiﬁer Gene name Protein name Log (e) n. spectra MW (kDa) Gel slice
1. ENSP00000351416ANKRD17 Ankyrin repeat domain 17 -54.9 9 274.1 A
2. ENSP00000448366SCYL2 SCY1-like 2 -18.1 3 77 A
3. ENSP00000392423RELN Reelin -7.9 3 388.1 A
4. ENSP00000376899PTGFRN Prostaglandin F2 receptor inhibitor -54.3 12 98.5 B
5. ENSP00000295598ATP1A1 ATPase, Na+/K+ transporting, alpha 1
polypeptide
-27.4 5 112.8 B
6. ENSP00000316032NUP98 Nucleoporin 98kDa -17.3 6 195.7 B
7. ENSP00000367122SLC3A2 Solute carrier family 3, member 2 -23.8 4 68 C
8. ENSP00000264883NUP54 Nucleoporin 54kDa -14.3 6 55.4 C
9. ENSP00000387282AGFG1 ArfGAP with FG repeats 1 -7.7 3 60.7 C
10. ENSP00000260130SDCBP Syndecan binding protein (syntenin) -10.7 3 32.4 E
11. ENSP00000221566SGTA Small glutamine-rich tetratricopeptide
repeat-containing, alpha
-10.3 3 34 E
12. ENSP00000227525TMEM109 Transmembrane protein 109 -35.2 15 26.2 G
Determination of HCV-associated cellular proteins by mass spectrometry.
Fig. 5. Validation of cellular proteins incorporated in HCV virions by
RNAi.Huh-7.5 cells were transfected with siRNA smartpools against the
indicated molecules and infected 48 hours later with Con1/Jc1 at low MOI
(0.05). (A, C) The percentage of HCV+ cells was determined 3 dpi by NS5A
staining and FACS analysis (white bars). (B, C) The number of HCV RNA
genomes released in the cell media was quantiﬁed by RT-qPCR (blacks bars).
(D) The infectivity of HCV particles produced by siRNA-transfected cells was
assessed by inoculating equal volumes of cell culture media on naïve Huh-7
cells. The number of NS5A+ cells was determined by FACS 3 dpi. In C-D, data
are expressed as percentage of scrambled siRNA.
material contained less than 50% of the input viral genomes, a
striking increase in the specific infectivity (FFU/genome RNAs)
of the particles was noted (from approximately 1/4000 for the
input material to 1/5 post-heparin purification; Table S1 and
Fig. S1B-C). This suggests that the heparin purification step
eliminates non-infectious RNA-containing particles and may ad-
ditionally remove factors inhibiting HCV infectivity. The heparin
column also removed >95% of the protein contaminants present
in the concentrated culture supernatant (Fig. S1A). The second
affinity purification step consisted of either antibody- or tag-
mediated capture of envelope containing HCV particles. In the
first case, a Con1-Jc1 virus with five adaptive mutations was
produced in serum-free media (SFM), concentrated, heparin-
Fig. 6. Nup98 interacts with Core and re-localizes to cLDs in infected cells.
(A) Cell lysates from naïve and clone2-infected Huh-7.5 cells (6 dpi) were
immunoprecipitated with anti-Nup98 antibody. Beads without antibody
(control beads) or conjugated to isotype-matched IgG served as negative
controls. Immunoblot analysis with anti-Nup98 and anti-Core antibodies are
shown. (B) Huh-7.5 cells infected with clone2 for 4 days were cryo-sectioned
and stained with antibodies to (a) Core, (b, d) Nup98 or (c) both. Repre-
sentative iEM images are shown. (a) Core is enriched on cLDs juxtaposed to
ER membranes. Membrane curvature may represent a nucleocapsid budding
event (arrowhead). Spherical particles within vacuoles may be HCV virions at
early maturation stage (stars). (c) Co-staining with Core (12nm) and Nup98
(6nm)-speciﬁc antibodies. (d)A low magniﬁcation image shows the expected
localization of Nup98 on both sides of the nuclear envelope, in the central
channel of the nuclear pore complex (NPC, see insert), and the additional
presence of Nup98 on cLD. Scale bars, 100 nm.
purified and incubated with a potent HCV-neutralizing antibody
that recognizes a discontinuous epitope encompassing E1 and E2
(AR4A; (4); Fig. 1A). For tag-mediated affinity purification, we
used a J6/JFH1 clone 2 infectious genome with a six histidine
(6xHis) tag and two copies of a Strep tag II fused to the N-
terminus of E2 (tag-clone 2; (3)) that was harvested in 1.5%
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Fig. 7. Impact of Nup98 on the HCV life cycle. (A) Immunoblot analysis
showing Nup98 and Core expression in Huh-7.5 expressing either shIRR or
shNup98 3 days post infection with HCV clone2. (B) shIRR or shNup98 cells
were infected with clone2 at the indicated MOI for 3 days and the % of
NS5A+ cells was determined by FACS analysis. Data are expressed as % of
infection measured in shNup98 compared to shIRR. (C-D) ShIRR and shNup98
cells were electroporated with Jc1FLAG2(p7-nsGluc2A) and Jc1FLAG2(p7-
nsGluc2A)/GNN RNAs. (C) Kinetics of luciferase secretion in cell culture media
wasmeasured between 6 and 72 hours post electroporation (hpe) tomonitor
viral RNA translation and replication. AR4A was added to the culture media
at 1μg/mL to minimize secondary rounds of infection. (D) Intracellular and
extracellular virus harvested from shNup98 and shIRR cells at 48 and 72 hpe
were inoculated onto naïve Huh-7.5. Infectivity was assessed by luciferase
quantiﬁcation and is shown as ratio of infection obtained with inocula
derived from shNup98 compared to shIRR cells
FBS (Fig. 1B). Tandem affinity purification using His-Dynabeads
and Streptactin beads was attempted but proved unsuccessful.
This might be partly due to particle aggregation post-elution
(Fig. S1F). His-Dynabeads resulted in lower background than
MagStrep beads and were therefore used for tag-mediated virion
purification (3). Production of HCV in FBS-containing media
yielded higher titer stocks than SFM. Moreover, tag-specific pu-
rification methods capture more virions compared to antibodies
targeting HCV glycoproteins (Fig. 2A; (3)). As a result, tag-HCV
but not Con1-Jc1 was subjected to buoyant density fractionation
prior to the second affinity capture step (Fig. 1). Several gradient
solutions were tested to achieve best separation of HCV virions
from protein contaminants, while preserving their infectivity.
Iodixanol gradients recovered >90% of the input infectivity in
three fractions (Fig. S1E).
Compositional analysis of HCV virions by mass spectrom-
etry. Transmission electron microscopy (TEM) of negatively
stained purified virions, used as input material for proteomics
analysis, revealed intact particles (Fig. 2A-B). Constituent pro-
teins in HCV-enriched samples were resolved by SDS-PAGE and
stained with Coomassie (Fig. 2C-D).
Viral proteins identifed in purified HCV virions. As a first step,
selected gel regions where Core, E1 and E2 are expected to
migrate (21, 35 and 70 kDa, respectively) were analyzed by liq-
uid chromatography-mass spectrometry (LC-MS) to determine
whether the purification protocols yielded sufficient material to
detect the major HCV structural components. Both purification
methods led to the identification of Core, E2 and the viral pro-
tease NS3 (Table 1). Table 1 lists the number of observed peptides
and the percent sequence coverage of the protein (corrected for
peptides unlikely to be observed by MS). The statistical score
associated with the match, log (e), is also noted. Core displayed
the highest relative abundance among the viral proteins using
both purification methods, based on the number of unique and
total peptides and the sequence coverage achieved. Overall, the
sample produced in SFM resulted in a lower LC-MS signal for
viral proteins. This is in agreement with the electron microscopy
images showing fewer virions in the input material (Fig. 2A).
Digestion of virion-associated Core with trypsin resulted in the
identification of peptides ending with arginine or lysine, as ex-
pected, with the exception of the most C-terminal peptide, which
ended with phenylalanine (Fig. 3). To exclude that this was due
to non-specific trypsin cleavage, the same sample was digested
with Asp-N; with similar results (Fig. S2). The C terminus of
the mature Core protein is produced by the host protease, SPP
but the form present in mature virions has not been determined
(5). Our results indicate that virion-incorporated Core is cleaved
at phenylalanine 177. Since E2 is a heavily glycosylated protein,
preliminary MS/LS sensitivity tests were conducted using a re-
combinant soluble E2 ectodomain (sE2; (6)). The identification
of unique E2 peptides and total spectra were dose-dependent,
with 6 unique peptides retrieved using the highest amount of
purified protein (70 femtomoles) and a detection limit of ∼ 4
femtomoles. Three of these peptides were also detected from
mature virions, using either purification approach (Table 1 and
Fig. S3). In the absence of PNGase F treatment, no peptides
with N-linked glycans were identified, in agreement with previous
studies (6). Given the lower amount of inputmaterial for the virus
preparation in SFM, the gel slices of the Con1/Jc1 sample were
cut in two and peptides were extracted with or without in-gel PN-
Gase F digestion. Deglycosylation increased the sensitivity of de-
tection for E2 from 3 to 4 unique peptides for the enzyme-treated
slice, with the additional peptide containing anNXTglycosylation
motif (Fig. S3G). While no E1 peptides were detected in PNGase
F-treated virus preparations, E1 incorporation in virions could be
inferred by the fact that the HCV-specific antibody used for the
purification recognizes a conformational epitope encompassing
E1/E2 (AR4A; (4)). Interestingly, the 70kDa gel region analyzed
for E2 detection also contained peptides of the viral protease
NS3. Three and one NS3 peptides were retrieved using both the
tag- and antibody-mediated virus capture, respectively, suggest-
ing that NS3 may be a virion component (Table 1).
Cellular proteins identified in purified HCV virions. Tag-
mediated purification, although successful for isolating intact viri-
ons, resulted in high protein background with significant contam-
ination from FBS-derived proteins, hampering the identification
of host proteins that specifically associate to HCV. Therefore, we
utilized the HCV neutralizing antibody AR4A as an alternative
approach to purify HCV virions . As a negative control, the
same amount of infectious particles was incubated with an HIV-
specific antibody (B6). A protein was considered a candidate
virion-associated factor if it satisfied all of the following criteria:
a) is not a known exogenous contaminant such as keratin b) the
log (e) score value does not exceed that of any protein identified
from the decoy database of reversed protein sequences and c)
both the main protein candidate identified by X!Tandem and its
homologues had zero spectrum counts in the corresponding con-
trol sample. In total, 46 human proteins were specifically isolated
with HCV virions (Table S2). These host factors were grouped
into functional categories including RNA binding, regulation of
gene expression, immunological and viral processes, intracellular
transport, lipid metabolism and endocytosis (Fig. 4 and Table S3).
Although apolipoproteins are known components of LVPs, they
are not in the list of HCV-associated host factors according to
the stringent inclusion criteria, because some peptides were also
found in the control lane. Nevertheless, human apoE, apoB-100,
apoA-II, apoC-II and C-III were enriched in purifiedHCV (Table
S4).
Validation of virion-associated host proteins. To corroborate
the proteomics data, 12 candidate cellular proteins were validated
in follow-up studies by RNA interference (Table 2). These host
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
4 www.pnas.org --- --- Footline Author
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
Submission PDF
factors were prioritized based on the following criteria: a) number
of observed peptides≥3; b) log (e)≤ -7 and c) previous implication
inHCVor other viral infections, based on pubmed search. SiRNA
smart pools targeting the HCV genome and the entry receptor
CD81 were used as positive controls for inhibition of viral in-
fection in our functional assays (Fig. 5). ApoB-100 and ApoA-
I siRNAs were also included in the analysis, as we previously
demonstrated specific incorporation of these host-derived pro-
teins in infectious HCV particles (3). Two days post-transfection
with siRNAs, Huh-7.5 cells were challenged with Con1/Jc1 at low
multiplicity of infection (MOI) and the number of NS5A positive
cells and viral genomes released in the culture media was mea-
sured 72 hours later by FACS and RT-qPCR, respectively (Fig.
5). Therefore, this assay mainly looked at the impact of protein
downregulation on secondary rounds of infection, determining a
cumulative effect of the host factors on HCV propagation rather
than discriminating between individual steps of the virus life cycle.
Cell viability wasmeasured by FACS from the same set of samples
at the time of harvesting (Fig. S4B). mRNA expression levels of
the targeted host factors were measured by real-time RT-PCR
to confirm decreased expression of the intended gene by specific
siRNAs (Fig. S4C). A striking decrease in the number of infected
cells (Fig. 5A, C and S4) and extracellular viral genomes (Fig.
5B-C) was observed in cells silenced for the nucleoporin Nup98.
This was paralleled by a 2-logs reduction in viral titers, when cell
culture media derived from siRNA-transfected cells was inocu-
lated onto naïve Huh-7 cells (Fig. 5D). Interestingly, silencing of
SCYL2 and PTGFRN resulted in a 75 and 60% increase in HCV
infection, respectively, suggesting an antiviral activity for these
host factors. Finally, moderate inhibition of infection (∼ 50%)
was observed in cells where endogenous SLC3A2, TMEM109,
ATP1A1 and SGTA were downregulated.
Nup98 interacts with Core and re-localizes to cytosolic lipid
droplets (cLD) in infected cells.Given the profound inhibition of
infection upon Nup98 silencing, we further investigated the role
of this protein in HCV biology. Since Nup98 was found in HCV
particles, we tested whether it bound to virion structural compo-
nents. We showed that Core specifically co-immunoprecipitates
with endogenous Nup98 (Fig. 6A). In physiological conditions,
Nup98 localizes at the nuclear envelope, being a component
of the nuclear pore complex (NPC) (7). Therefore, the role
of Nup98 in HCV infection and its packaging into virions was
unexpected considering that HCV replicates in the cytoplasm.
To understand where the interaction between Nup98 and Core
occurs, we performed immunofluorescence and electron mi-
croscopy (iEM) studies of infected Huh-7.5 cells. Differences
in Nup98 subcellular distribution were observed at early versus
late stages of infection. Initially, Nup98 staining is comparable
to uninfected cells, mainly localizing at the nuclear envelope. In
contrast, 6 days post-infection, Nup98 is enriched on large, round
cytoplasmic structures where also Core localizes (Fig. S5A-B).
Core is known to accumulate on cLD, cytoplasmic organelles for
lipid storage, prior to being utilized for the nucleation of viral
capsids (8). To confirm that Core and Nup98 were co-localizing
on cLD, we used the Tokuyasu technique for immunolabelling of
cryosections (9). The expected staining of Core on the surface of
cLD was observed. Furthermore, Nup98 was shown to re-localize
to cLD, while retaining its physiological localization at the nuclear
envelope (Fig. 6B). Co-staining with Core and Nup98-specific
antibodies by iEM confirmed that the two proteins co-localize on
the surface of cLD in infected cells (Fig. 6B and S5C).
Nup98 is required for HCV morphogenesis. To dissect the
role of Nup98 in HCV biology, Huh-7.5 cells were transduced
with lentiviral particles encoding either irrelevant or Nup98-
specific shRNAs (Fig. 7). The two cell lines were compared
using viral assays that looked at specific steps of the HCV life
cycle. HCV infection was impaired in cells where Nup98 protein
expression was downregulated, as shown by the reduction of
intracellular Core levels (Fig. 7A). The negative impact of Nup98
silencing on infection was overcome in a dose-dependent manner
by using higherMOI, suggesting that the block is not at the level of
virus entry or early steps of infection (Fig. 7B). Accordingly, using
a luciferase-reporter Jc1 virus, we showed that HCV replication
and translation were comparable between shIRR and shNup98
cells (Fig. 7C). In contrast, the amount of both intracellular and
extracellular infectious particles produced by shNup98 cells was
reduced by 50% and 90%, respectively compared to control cells,
indicating a role for Nup98 in the late steps of virion biogenesis
(Fig. 7D).
Discussion
In the last decade, substantial progress in growing HCVcc has
been made by using highly permissive cell lines and by selecting
more fit viral genomes with adaptive mutations (10). Neverthe-
less, HCVcc titers remain in the range of 105-106 tissue culture
infectious dose50 (TCID50) per ml, which is approximately 100 to
a 1000-fold less than other enveloped viruses for which protein
composition has been determined (1). If higher virus yields are
achieved when serum is added to the culture media, contamina-
tion by highly abundant serum proteins compromises the ability
to detect cellular proteins that are anticipated to be packaged
into HCV virions in low copy numbers (Fig. 2). Furthermore,
poor stability of virions makes the purification process extremely
time-sensitive, limiting the number of purification steps that can
be undertaken before most of the infectivity is lost (11). Finally,
propensity to forming aggregates has been observed, preventing
tandem affinity purification approaches (Fig. S1).
We undertook appropriate complementary approaches to
compositional studies of extracellular HCV virions, using differ-
ent viral genomes and affinity purification methods. Up to 15
liters of virus-containing supernatant were produced for this study
and culture media was harvested frequently and stored at 4C to
prevent virus inactivation (Fig. 1). More infectious virus parti-
cles (∼ 5-10 folds) were being produced using FBS-containing
media and these virions were better captured using tag- rather
than antibody-mediated purification methods (3). Accordingly,
a better sequence coverage of viral proteins was achieved by
LC/MSusingHCV samples produced in serum. Conversely, HCV
isolation via glycoprotein-specific antibodies was more effective
with preparations in SFM and resulted in significantly cleaner
virion pull downs (Fig. 2). However, lower viral titers were
achieved in SFM, hampering further fractionation approaches by
ultracentrifugation.
Despite these differences, both approaches led to the iden-
tification of the same set of viral proteins, with Core displaying
the highest sequence coverage (Table 1). Previous studies have
shown that Core is cleaved by SPP at Phe 177 and that aa 1-177
of the protein are necessary and sufficient for HCV infectivity
(5, 12). Using purified HCV virions fractionated over buoyant
density gradient, we now determined that the C-terminus of Core
packaged in infectious particles is Phe 177 (Fig. 3 and S2).
In addition to the expected structural viral proteins, the pro-
teaseNS3 was also identified in virions produced in FBS as well as
SFM, using different purification methods (Table 1). A possible
explanation for this may be that incoming HCV particles would
benefit from having a viral protease that can promptly inactivate
cytoplasmic viral sensors upon capsid uncoating, prior to the
formation of the membranous web. Alternatively, given its role in
HCV assembly, NS3 may be incorporated in virions by proximity
(2). The low signal compared toCore andE2 is consistent with the
expectation of the protease not being incorporated in high-copy
numbers.
The present study reveals an intimate interplay betweenHCV
and the host in the make-up of infectious particles, with 46 po-
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tential cellular proteins incorporated into mature virions (Table
S2), belonging to a variety of functional classes (Fig. 4). While it
is unclear whether all these cellular proteins represent true virion
components or are only peripherally associated to HCV particles,
some of them were previously linked to viral processes (Table S3)
and are specifically regulated during HCV infection (13).
Two of these proteins, PTGFRN and SCYL2, display antivi-
ral roles not only against HCV (Fig. 5 and S4) but also other
pathogens. PTGFRN (also called CD9P-1 or EWI-F) inhibits the
ability of hepatocytes to support Plasmodium sporozoite infection
by interacting with CD81 (14). Interestingly, PTGFRNwas shown
to be upregulated inHCV-infected cells (13). The IFN-stimulated
gene SCYL2 is a component of clathrin-coated vesicles, involved
in membrane trafficking between the trans-Golgi and endosomes
and it was shown to restrict HIV release by inhibiting the viral
protein Vpu (15). Further investigations will be required to de-
termine how these host factors counteract HCV infection and
whether they can be considered bona fide restriction factors.
Conversely, Nup98 displayed the strongest pro-viral pheno-
type, with a profound reduction in viral genome release and in-
fectious titers upon silencing (Fig. 5). A previous study identified
Nup98 as an important host protein for HCV infection (16).
Here, we show for the first time that Nup98 is co-purified with
extracellularHCV virions (Table 2), physically interacts with Core
(Fig. 6 and S5) and is specifically required for late stages of the
HCV life cycle – assembly/maturation (Fig. 7). Follow up studies
will determine whether Nup98’s impact on HCV biogenesis is
direct or can also be explained by Nup98 modulation of cellular
gene expression.
Nup98 dynamically associates to the NPC, where it regu-
lates nucleo-cytoplasmic transport of mRNAs and proteins (7).
We propose that HCV hijacks Nup98 physiological functions
to transport HCV structural components from different cellular
compartments, thus coordinating virion morphogenesis. Accord-
ingly, several HCV proteins, including Core, contain functional
nuclear localization signals (NLS) and nuclear export signals
(NES) sequences that are required to bind cargo proteins and
cross the NPC (17). This would be in agreement with the model
suggested by Neufeldt et al, which hypothesizes the insertion of
NPC in the cytoplasm of infected cells to compartmentalize virus
replication/assembly (16). To date, viruses have been described
to target the NPC to cross the nuclear envelope and/or to con-
trol host transcription. In contrast, our proteomics, biochemical
and ultrastructural data suggest a novel mechanism of Nup98
exploitation to aid virus assembly.
In summary, we report the first compositional analysis of
extracellular HCV particles. Future studies will address the func-
tional roles that other HCV-associated host factors may fulfill
during specific steps of the virus life cycle. This will further our
understanding of the host contribution to HCV propagation and
pathogenesis.
Materials and Methods
Virion Puriﬁcation. HCV stocks were created by electroporating viral RNA
into Huh-7.5.1 cells (18). Cells were switched to low-serum (1.5% FBS) or
serum free (SFM) media 12 hours post electroporation (hpe) and virus-
containing media was harvested every 3-6 hours up to 5 days post electropo-
ration. Viral supernatants were concentrated in a stirred ultraﬁltration cell
(Model 8400 with 100-kDa MWCO membranes; Millipore) and puriﬁed over
heparin column (GE Hitrap Heparin). Heparin-bound HCV was eluted with
0.02M Tris-HCl pH 7.4; 0.5M NaCl and dialyzed with PBS1X using Amicon-
Ultra centrifugation devices (regenerated cellulose, low-protein binding
capacity; Millipore, MWCO 100kDa). Heparin-eluted Con1/Jc1 was incubated
with ProtA-coated magnetic beads (Bio-Adembeads; Ademtech) conjugated
to antibodies speciﬁc to HCV (AR4A) or HIV (B6) envelope glycoproteins
and eluted in SDS buffer. Heparin-eluted clone 2-His/OST (tag) and wild-
type (wt) viruses were fractionated over a 10-40% (w/v) iodixanol buoyant
density gradient (Optiprep; Sigma) (3). Fractions with the highest infectivity
were incubated with His-Dynabeads (Invitrogen) for 1h at RT in the presence
of 20mM imidazole and protease inhibitors. Bound particles were washed
50mM imidazole and eluted with 900mM imidazole (in PBS1X, pH 7.7).
Proteomics analysis. Gel lanes were sliced in 1 mm intervals and slices
were pooled into 6 samples. Slices were cubed, destained with 50% v/v
acetonitrile in 50 mM ammonium bicarbonate. To deglycosylate proteins,
gel pieces were incubated with 80μl of PNGase F (11 units/μl; New England
BioLabs) in 50 mM sodium phosphate pH 7.5 at 37°C overnight, then washed
four times with water the next day. Proteins were digested overnight in
3.1ng/μl trypsin (Promega, Madison, WI) in 25 mM ammonium bicarbon-
ate. Peptides were extracted with 2.5 mg/ml POROS R2 20 µm beads (Life
Technologies, Grand Island, NY) in 5% formic acid, 0.2% TFA on a shaker at
4°C for 24 hours. Digests were desalted on Stage Tips, eluted, concentrated
by SpeedVac, and loaded onto a 75 µm ID PicoFrit column (New Objective,
Woburn, MA) packed in-house with 6 cm of reverse-phase C18 material (5
µm particles, 300 Å pores, YMC∗Gel ODS-A, YMC, Allentown, PA). Peptides
were gradient-eluted (using 0.1 M acetic acid, and 0.1 M acetic acid in
70% acetonitrile, ﬂow rate 200 nl/min) into an LTQ-Orbitrap-XL mass spec-
trometer (Thermo Fisher Scientiﬁc, Waltham,MA) acquiring data-dependent
CID fragmentation spectra. Using the X!Tandem algorithm, raw data were
searched against databases of human, bovine, and HCV protein sequences,
as well as a decoy database of reversed protein sequences.
Detailed methods can be found in SI Materials and Methods.
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